{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "After a panel of medical experts gave a very cautious nod to the continued use of the painkillers Celebrex, Vioxx and Bextra on Friday, pain management experts said they expected to see the same caution transform the way the painkillers are prescribed from now on. The drugs, which had been hugely popular for people with both short-term and chronic pain, will be prescribed much less readily, for a smaller group of patients, at lower doses and for shorter periods, the experts said.", "headline": {"main": "For Pain Management, Doctors Prescribe Caution"}, "abstract": "Panel of medical experts warns that painkillers Celebrex, Vioxx and Bextra increase risk of heart attack and stroke and recommends that Food and Drug Administration place new warnings on labels, but also holds that benefits to some patients outweigh risks and that drugs should remain on market; many candidates for these drugs are same ones at risk for heart attack; doctors recommend taking lower doses of drugs and avoiding taking them for extended periods; chart (M)", "print_page": "1", "word_count": 1385, "_id": "4fd2a5e08eb7c8105d88db8f", "snippet": "Pain management experts said they expected Celebrex, Vioxx and Bextra to be prescribed much less readily.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/20/health/20pain.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "BEXTRA (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "VIOXX (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Mary", "rank": 1, "lastname": "DUENWALD"}], "original": "By MARY DUENWALD; Anahad O'Connor contributed reporting from New York for this article, and Gardiner Harris from Washington"}, "document_type": "article", "pub_date": "2005-02-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Almost every headline about the remarkable hearings this week by a federal drug advisory panel focused on whether several huge-selling pain pills were safe. Just as significant, though, was what may well be the start of a cultural transformation at the Food and Drug Administration. Instead of certainty, the agency embraced doubt. Instead of presenting a united front, agency officials bickered openly. Instead of keeping secret its dealings with drug companies, the agency gave a public accounting of lengthy and contentious negotiations with the drug maker Merck.", "headline": {"main": "F.D.A. Moves Toward More Openness With the Public"}, "abstract": "Series of embarrassing scandals forces Food and Drug Administration to bring 'transparency' to agency; unrelenting investigation by Sen Charles E Grassley has made creating new agency culture matter of political survival; changes are small so far, but were demonstrated in openness and frankness of dealings of this week's drug advisory panel discussing possible dangers of some older painkillers; photo (M)", "print_page": "28", "word_count": 982, "_id": "4fd25ae48eb7c8105d807728", "snippet": "Almost every headline about the remarkable hearings this week by a federal drug advisory panel focused on whether several huge-selling pain pills were safe. Just as significant, though, was what may well be the start of a cultural transformation at...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A0CEFDE1E3AF933A15751C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GRASSLEY, CHARLES E"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2005-02-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Westchester Weekly Desk", "lead_paragraph": "JOSHUA BENEDEK, a University of Connecticut student home on summer break in July 2003, was planning for that sloppy American rite of passage, the 21st birthday party. Finally of legal drinking age, he considered holding court at a bar and flashing identification that could suddenly fetch a beer or a shot of tequila with no questions asked. But several of his friends were not yet 21, the Horace Greeley High School graduate said by phone from college, and he decided to have a party at the family home instead.", "headline": {"main": "Alcohol Wars Give 'Party Jitters' A Whole New Meaning"}, "abstract": "Article on crackdown by Westchester County District Attorney Jeanine Pirro's on under-age drinking; Paul and Christine Taxin of Greenburgh are latest of handful of parents in last decade who have been arrested for allowing youths under 21 to drink at parties in their homes; evidence suggests that majority of parents share Pirro's view that if parents do not want to be held responsible, they should not have parties where older teenagers drink; photos (L)", "print_page": "1", "word_count": 2469, "_id": "4fd2839d8eb7c8105d851d2d", "snippet": "Adults who supervise parties where young people, sometimes under age, drink in their homes, are being increasingly assailed as abettors.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/20/nyregion/thecity/20WE.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PIRRO, JEANINE F"}, {"name": "persons", "value": "TAXIN, PAUL"}, {"name": "persons", "value": "TAXIN, CHRISTOPHER"}, {"name": "glocations", "value": "WESTCHESTER COUNTY (NY)"}, {"name": "subject", "value": "ALCOHOL ABUSE"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "PARTIES (SOCIAL)"}, {"name": "subject", "value": "ALCOHOLIC BEVERAGES"}, {"name": "subject", "value": "DRUNKEN AND RECKLESS DRIVING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "David", "rank": 1, "lastname": "SCHARFENBERG"}], "original": "By DAVID SCHARFENBERG"}, "document_type": "article", "pub_date": "2005-02-20T00:00:00Z", "section_name": "New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A top Merck research official suggested to a federal drug advisory panel on Thursday that the company might soon decide to start reselling the painkiller Vioxx in the United States, despite risks it may pose to the heart. The official, Dr. Peter Kim, Merck's research chief, said that if the panel decided that Celebrex and Bextra, drugs similar to Vioxx, also hurt the heart, ''then that would be important to us to take that into consideration with regard to Vioxx.''", "headline": {"main": "Merck May Resume Sales Of Painkiller, Official Says"}, "abstract": "Dr Peter Kim, Merck's research chief, says company may decide to start reselling painkiller Vioxx in US, despite risks it may pose to heart; says if FDA and federal drug advisory panel investigating cox-2 inhibitors conclude benefits as class of drugs outweigh risks, then Merck will consider re-entering market; news is remarkable in already landmark hearing as panel members sift through studies trying to weigh risks and benefits of Vioxx, Bextra and Celebrex (M)", "print_page": "18", "word_count": 952, "_id": "4fd244408eb7c8105d7de8cb", "snippet": "A top research official suggested that the company might soon decide to start reselling Vioxx, despite risks it may pose to the heart.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/18/politics/18fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KIM, PETER"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "organizations", "value": "MERCK & COMPANY INCORPORATED"}, {"name": "organizations", "value": "MERCK & CO"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "BEXTRA (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "ARTHRITIS AND RHEUMATISM"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "COX-2 INHIBITORS (DRUGS)"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}, {"name": "subject", "value": "VIOXX (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2005-02-18T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "The yearlong debate over whether antidepressant drugs increase the risk of suicide in some children may soon widen to include adults, as English and Canadian scientists are reporting findings from three new analyses of suicide risk in people over age 18 who have taken the medications. The new findings are mixed, and apparently contradictory, and likely to encourage both patient advocates who believe that antidepressants like Prozac have hidden dangers, and manufacturers who insist that the medications are safe, experts said.", "headline": {"main": "Antidepressant Safety Debate May Include Adult Patients"}, "abstract": "Yearlong debate over whether antidepressant drugs increase risk of suicide in some children may soon widen to include adults; English and Canadian scientists report findings from three new analyses of suicide risk in people over age 18 who have taken medications; findings are mixed and apparently contradictory, likely to encourage both patient advocates who believe Prozac and other antidepressants have hidden dangers, and manufacturers who insist medications are safe; all three papers on subject appear in online version of British Medical Journal (M)", "print_page": "17", "word_count": 766, "_id": "4fd24a4e8eb7c8105d7e83a4", "snippet": "English and Canadian scientists are reporting findings from three new analyses of suicide risk in people over age 18 who have taken the medications.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/18/national/18depress.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "GREAT BRITAIN"}, {"name": "glocations", "value": "CANADA"}, {"name": "organizations", "value": "BRITISH MEDICAL JOURNAL"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "ANTIDEPRESSANTS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "SUICIDES AND SUICIDE ATTEMPTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Benedict", "rank": 1, "lastname": "CAREY"}], "original": "By BENEDICT CAREY"}, "document_type": "article", "pub_date": "2005-02-18T00:00:00Z", "section_name": "World; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Human rights groups and academic researchers are stepping up calls for safety studies and national standards governing the use of electric stun guns after a series of deaths as well as incidents in which the weapons were used against children. Sale of the guns to police departments has slowed since last fall, with some police chiefs saying they do not plan to deploy them without more research into their safety. But other departments are moving forward.", "headline": {"main": "Demands Rise for Tighter Oversight on Use of Stun Guns"}, "abstract": "Human rights groups and researchers step up calls for safety studies and national standards governing use of electric stun guns after series of deaths and incidents in which weapons were used on children; some police departments are hesitant to deploy them, but others are moving forward; guns are made by Taser International and are unregulated; since 2000, almost 100 people around country have died after being shocked, although medical examiners rarely cite stun guns as cause of death; photos (M)", "print_page": "24", "word_count": 925, "_id": "4fd25ae38eb7c8105d8076e2", "snippet": "Some people are calling for standards governing the use of electric stun guns after a series of deaths as well as incidents in which the weapons were used against children.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/17/national/17tasers.html", "multimedia": [{"url": "images/2005/02/17/national/taser.7575.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/02/17/national/taser.7575.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "TASER INTERNATIONAL"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "STUN GUNS"}, {"name": "subject", "value": "POLICE"}, {"name": "subject", "value": "FIREARMS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Alex", "rank": 1, "lastname": "BERENSON"}], "original": "By ALEX BERENSON"}, "document_type": "article", "pub_date": "2005-02-17T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "If nothing else, the AIDS case that alarmed health officials in New York last week illustrates the enormous difficulty of promoting and sustaining changes in sexual behavior, social scientists say. The man at the center of the furor, who officials fear may carry a rare and possibly virulent strain of H.I.V., reportedly engaged in unprotected sex with hundreds of partners in recent months and took the drug crystal methamphetamine.", "headline": {"main": "How to Get Those at Risk To Avoid Risky Sex?"}, "abstract": "Public health campaigns designed to discourage unprotected sex and curb spread of HIV and AIDS are not reaching or impacting segment of population most likely to engage in risky sex; Centers for Disease Control and Prevention survey of 33 US cities finds that new AIDS and HIV cases increased by 1 percent from 1999 to 2003; drug abuse has been found to be key component in risky sex; Explore project, study designed to measure impact of counseling on sexual risk-taking, finds that those individuals who received counseling use safe sex practices immediately following information sessions, but over two years following study lost motivation to maintain safe-sex life styles; photo (M)", "print_page": "1", "word_count": 1320, "_id": "4fd245fa8eb7c8105d7e07c2", "snippet": "The AIDS case that alarmed health officials in New York last week illustrates the enormous difficulty of promoting and sustaining changes in sexual behavior.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/02/15/health/15beha.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "CENTERS FOR DISEASE CONTROL AND PREVENTION"}, {"name": "subject", "value": "LIFE STYLES"}, {"name": "subject", "value": "SEX"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "CONDOMS"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "URBAN AREAS"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Benedict", "rank": 1, "lastname": "CAREY"}, {"organization": "", "role": "reported", "firstname": "Anahad", "rank": 2, "lastname": "O'CONNOR"}], "original": "By BENEDICT CAREY and ANAHAD O'CONNOR"}, "document_type": "article", "pub_date": "2005-02-15T00:00:00Z", "section_name": "Science; Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "Despite all the advances of modern medicine, the main drugs used to fight pain today are essentially the same as those used in ancient times. Hippocrates wrote about the pain-soothing effects of willow bark and leaves as early as 400 B.C. Opium was cultivated long before that. Aspirin and morphine, based on the active ingredients in these traditional remedies, were isolated in the 1800's and helped form the foundation of the modern pharmaceutical industry.", "headline": {"main": "The Search for the Killer Painkiller"}, "abstract": "Tens of millions of Americans suffer from chronic pain and recent withdrawal of some painkillers from US marketplace leaves those in pain with few alternatives; classic pain medications and treatments described; Remi Barbier, Pain Therapeutics chief executive, asserts that drug research needs to examine and re-examine potential painkillers and fill void to help patients cope with day to day pain; molecular mechanisms that perceive pain and some natural remedies that block pain transmission discussed; researchers hold that combination of drugs may be required to adequately block pain; photos; drawings (L)", "print_page": "1", "word_count": 2323, "_id": "4fd2571c8eb7c8105d80143c", "snippet": "Despite all the advances of modern medicine, the main drugs used to fight pain today are essentially the same as those used in ancient times.     Hippocrates wrote about the pain-soothing effects of willow bark and leaves as early as 400 B.C. Opium...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F0CEFD7153AF936A25751C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BARBIER, REMI"}, {"name": "organizations", "value": "PAIN THERAPEUTICS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2005-02-15T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 8, "offset": 0, "time": 63}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}